Market Overview

The Global Self-Monitoring Blood Glucose Market was valued at USD 15,704.0 million in 2023 and is expected to reach USD 26,383.1 million by 2031 while growing at a CAGR of 6.7% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global self-monitoring blood glucose market growth. Self-monitoring of blood glucose (SMBG) plays a crucial role in contemporary diabetes mellitus therapy. It's strongly advised for individuals with diabetes and their healthcare providers to achieve targeted glycemic control and avoid hypoglycemia. The objective of SMBG is to gather comprehensive data on blood glucose levels throughout the day, enabling the implementation of precise treatment regimens to maintain more stable glucose levels.

The increasing prevalence of diabetes, coupled with growing awareness and education about glycemic control, and a shift towards patient-centric care, fuels market growth. However, cost constraints and technological limitations pose barriers to market expansion.

Furthermore, the global self-monitoring blood glucose industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Component Analysis

The Global Self-Monitoring Blood Glucose Market is segmented among Glucometer Devices, Test Strips, and Lancets, based on Component. In 2023, Test Strips accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By End User Analysis

The Global Self-Monitoring Blood Glucose Market is segmented among Hospital/Clinics, and Personal/Home, based on End User. In 2023, Hospital/Clinics accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Self-Monitoring Blood Glucose Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Abbott, F. Hoffmann-La Roche AG, LifeScan, Arkray, Ascensia, Agamatrix Inc., Bionime Corporation, Acon, Medisana, and Trivida

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Self-Monitoring Blood Glucose Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Self-Monitoring Blood Glucose Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Self-Monitoring Blood Glucose Market Segmentation, By Component

• Global Self-Monitoring Blood Glucose Market Share Analysis, By Component

• Global Self-Monitoring Blood Glucose Market Growth Analysis, By Component

• Global Self-Monitoring Blood Glucose Market Trends, By Component

o Glucometer Devices

o Test Strips

o Lancets

6. Global Self-Monitoring Blood Glucose Market Segmentation, By End User

• Global Self-Monitoring Blood Glucose Market Share Analysis, By End User

• Global Self-Monitoring Blood Glucose Market Growth Analysis, By End User

• Global Self-Monitoring Blood Glucose Market Trends, By End User

o Hospital/Clinics

o Personal/Home

7. Global Self-Monitoring Blood Glucose Market Segmentation, By Region

• Global Self-Monitoring Blood Glucose Market Share Analysis, By Region

• Global Self-Monitoring Blood Glucose Market Growth Analysis, By Region

• Global Self-Monitoring Blood Glucose Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Abbott*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• F. Hoffmann-La Roche AG

• LifeScan

• Arkray

• Ascensia

• Agamatrix Inc.

• Bionime Corporation

• Acon

• Medisana

• Trivida

*Similar analysis will be provided for each company listed above.